MN Services Vermogensbeheer’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Hold
35,500
0.01% 458
2025
Q1
$2.51M Buy
35,500
+3,800
+12% +$269K 0.02% 438
2024
Q4
$2.08M Hold
31,700
0.01% 461
2024
Q3
$2.23M Hold
31,700
0.02% 463
2024
Q2
$2.61M Hold
31,700
0.02% 455
2024
Q1
$2.77M Sell
31,700
-54,400
-63% -$4.75M 0.02% 462
2023
Q4
$8.3M Sell
86,100
-3,300
-4% -$318K 0.07% 279
2023
Q3
$7.91M Hold
89,400
0.08% 275
2023
Q2
$7.75M Buy
+89,400
New +$7.75M 0.07% 291
2019
Q3
Sell
-30,631
Closed -$2.62M 381
2019
Q2
$2.62M Hold
30,631
0.03% 475
2019
Q1
$2.72M Buy
30,631
+500
+2% +$44.4K 0.03% 446
2018
Q4
$2.24M Buy
30,131
+2,300
+8% +$171K 0.03% 435
2018
Q3
$2.7M Hold
27,831
0.06% 326
2018
Q2
$2.62M Sell
27,831
-1,200
-4% -$113K 0.07% 325
2018
Q1
$2.35M Buy
29,031
+1,900
+7% +$154K 0.06% 345
2017
Q4
$2.02M Sell
27,131
-1,500
-5% -$111K 0.06% 327
2017
Q3
$2.67M Hold
28,631
0.07% 303
2017
Q2
$2.6M Buy
28,631
+24,044
+524% +$2.18M 0.07% 305
2017
Q1
$376K Buy
4,587
+166
+4% +$13.6K 0.07% 295
2016
Q4
$347K Buy
4,421
+260
+6% +$20.4K 0.07% 300
2016
Q3
$385K Buy
4,161
+79
+2% +$7.31K 0.08% 285
2016
Q2
$286K Buy
4,082
+90
+2% +$6.31K 0.07% 322
2016
Q1
$289K Buy
+3,992
New +$289K 0.07% 322